New insulin put to the test against market leaders
NCT ID NCT07165652
First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 20 times
Summary
This study checked if a new insulin (NKF-INS(L)) works the same way in the body as two already-approved insulins (US-Humalog and EU-Humalog). Fifty-four healthy men received a single dose of each insulin in a random order, and their blood sugar and insulin levels were measured. The goal was to see if the new insulin is similar enough to be used as a substitute.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE ADULT VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
FARMOVS
Bloemfontein, 9301, South Africa
Conditions
Explore the condition pages connected to this study.